We are live on ! Find out more
PR

PSP Research Portfolio holdings

AUM $188M
This Fund
S&P 500
This Quarter Est. Return
+18.09%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$114M
AUM Growth
Cap. Flow
+$110M
Cap. Flow %
96.55%
Top 10 Hldgs %
65.84%
Holding
85
New
85
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 38.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMCR icon
76
Immunocore
IMCR
$1.91B
$501K 0.44%
+14,424
New +$509K
KYMR icon
77
Kymera Therapeutics
KYMR
$10.4B
$494K 0.43%
+6,348
New +$429K
UPB
78
Upstream Bio Inc
UPB
$391M
$479K 0.42%
+17,634
New +$439K
OLMA icon
79
Olema Pharmaceuticals
OLMA
$949M
$477K 0.42%
+19,063
New +$339K
COGT icon
80
Cogent Biosciences
COGT
$6.37B
$470K 0.41%
+13,233
New +$372K
GPCR icon
81
Structure Therapeutics
GPCR
$3.52B
$467K 0.41%
+6,719
New +$274K
DFTX
82
Definium Therapeutics
DFTX
$5.88B
$467K 0.41%
+34,841
New +$431K
ARWR icon
83
Arrowhead Research
ARWR
$12.6B
$444K 0.39%
+6,689
New +$328K
ALMS
84
Alumis Inc
ALMS
$3.06B
$427K 0.37%
+43,769
New +$306K
DYN icon
85
Dyne Therapeutics
DYN
$4.92B
$421K 0.37%
+21,535
New +$408K

Similar funds

PSP Research's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for PSP Research, which disclosed 85 positions worth $114M. Its ten largest holdings account for 66% of the portfolio.

Its largest position is iShares 0-3 Month Treasury Bond ETF: 700,000 shares worth $70.3M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets.

  • PSP Research's largest Q4 2025 buy was iShares 0-3 Month Treasury Bond ETF: 700,000 shares worth $70.3M.
  • PSP Research's ten largest holdings make up 66% of its $114M portfolio in Q4 2025.
  • PSP Research disclosed 85 positions in Q4 2025, its first 13F filing on record.

Based on PSP Research's 13F filing for Q4 2025, filed 6 Feb 2026.